Results 41 to 50 of about 103,766,681 (205)

Durable natural killer cell response after three doses of SARS-CoV-2 inactivated vaccine in HIV-infected individuals

Chinese Medical Journal, 2023
. Background:. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine can induce a potent cellular and humoral immune response to protect against SARS-CoV-2 infection.
Xiaodong Yang, Xiuwen Wang, Xin Zhang, Haifeng Ding, Hu Wang, Tao Huang, Guanghui Zhang, Junyi Duan, Wei Xia, Bin Su, Cong Jin, Hao Wu, Tong Zhang, Sihan Zhou, Xiuyuan Hao   +14 more
doaj   +1 more source

Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa.

PLoS ONE, 2023
ObjectivesThis study aimed to confirm the co-infection with HIV-1 and HIV-2, among West African patients using in-house HIV type/group enzyme-immuno assays and molecular diagnosis.DesignA cross-sectional survey was conducted from April 2016 to October ...
Boris K Tchounga, Mélanie Bertine, Florence Damond, Valentine Marie Ferré, André Inwoley, Simon P Boni, Alice Moisan, Jean-Christophe Plantier, Diane Descamps, Didier K Ekouevi, Charlotte Charpentier   +10 more
doaj   +1 more source

Progress in voluntary medical male circumcision for HIV prevention supported by the US President’s Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data

BMJ Open, 2018
Objective This article provides an overview and interpretation of the performance of the US President’s Emergency Plan for AIDS Relief’s (PEPFAR’s) male circumcision programme which has supported the majority of voluntary medical male circumcisions ...
Carlos Toledo, Melissa Habel, Stephanie M Davis, Jonas Z Hines, Jonathan M Grund, Renee Ridzon, Brittney Baack, Jonathan Davitte, Anne Thomas, Valerian Kiggundu, Naomi Bock, Paran Pordell, Caroline Cooney, Irum Zaidi   +13 more
doaj   +1 more source

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. [PDF]

, 2010
BACKGROUND: The prevalence of HIV/hepatitis co-infection in sub-Saharan Africa is not well documented, while both HIV and HBV are endemic in this area.
Jobarteh Modou, Mendy Maimuna, Cotten Matt, Tedder, Richard, Sarge-Njie Ramu, Peterson, Ingrid, Peterson Ingrid, Richard Tedder, Rowland-Jones, Sarah, Malfroy Marine, Maimuna Mendy, Jobarteh, Modou, Cotten, Matt, Tedder Richard, Hilton Whittle, Matt Cotten, Sarge-Njie, Ramu, Sarah Rowland-Jones, Ingrid Peterson, Peterson, Kevin, Peterson Kevin, Jaye Assan, Jaye, Assan, Mendy, Maimuna, Whittle Hilton, Modou Jobarteh, Hall, Andrew, Hall Andrew, Jeng Adam, Alabi, Abraham, Ramu Sarge-Njie, Malfroy, Marine, Alabi Abraham, Assan Jaye, Whittle, Hilton, Adam Jeng, Rowland-Jones Sarah, Andrew Hall, Jeng, Adam, Kevin Peterson, Marine Malfroy, Abraham Alabi   +41 more
core   +1 more source

Novel assays to investigate the mechanisms of latent infection with HIV-2.

PLoS ONE, 2022
Although there have been great advancements in the field of HIV treatment and prevention, there is no cure. There are two types of HIV: HIV-1 and HIV-2.
Michael D Lu, Sushama Telwatte, Nitasha Kumar, Fernanda Ferreira, Holly Anne Martin, Gayatri Nikhila Kadiyala, Adam Wedrychowski, Sara Moron-Lopez, Tsui-Hua Chen, Erin A Goecker, Robert W Coombs, Chuanyi M Lu, Joseph K Wong, Athe Tsibris, Steven A Yukl   +14 more
doaj   +1 more source

Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. [PDF]

, 2010
BACKGROUND: There have been no previous studies of the long-term survival and temporal changes in plasma viral load among HIV-2 infected subjects. METHODS: 133 HIV-2 infected and 158 HIV-uninfected subjects from a rural area in North-west Guinea-Bissau ...
Jaye, Assan, Kaye, Steve, van der Loeff, Maarten F Schim, Steve Kaye, Aaby, Peter, Alabi, Abraham, Ramu Sarge-Njie, Dominique Ricard, Sarah Jones, Larke, Natasha, Aleksandra Leligdowicz, Tim Vincent, Maarten van der Loeff, Assan Jaye, Jaffar, Shabbar, Neil Berry, Berry, Neil, Ricard, Dominique, Koya Ariyoshi, Whittle, Hilton, da Silva, Zacharias, Jones, Sarah Rowland, Leligdowicz, Aleksandra, Shabbar Jaffar, Peter Aaby, van Tienen, Carla, Vincent, Tim, Hilton Whittle, Zacharias da Silva, Sarge-Njie, Ramu, Abraham Alabi, Carla van Tienen, Ariyoshi, Koya, Natasha Larke   +33 more
core   +1 more source

Blood preparations of humans and animals in terms of their quality, efficacy and safety

Биопрепараты: Профилактика, диагностика, лечение, 2018
The problems of quality and safety products derived from human blood plasma and hyperimmune animal sera as well as recombinant blood products resolved strict government regulation of their production processes.
M. V. Supotnitsky, A. A. Elapov, I. V. Borisevich, E. Yu. Kudasheva, V. I. Klimov, E. V. Lebedinskaya, L. V. Korsun, E. V. Gorbunova, V. G. Slobodayn, V. A. Merkulov, Yu. V. Olefir   +10 more
doaj  

Commercial sex and the spread of HIV in four cities in sub-Saharan Africa. [PDF]

, 2001
OBJECTIVE: To examine whether commercial sex transactions were more common and/or transmission between sex workers and clients more efficient in two African cities with high HIV prevalence (Kisumu, Kenya and Ndola, Zambia) compared with two with ...
Morison, L., Caraël, M, Weiss, HA, Kanhonou, L., Hayes, R. J., Chege, J., Buvé, A, Buvé, A., Abega, S. C., Weiss, H. A., Study Group on Heterogeneity of HIV Epidemics in African Cities, Caraël, M., Chege, J, Kanhonou, L, Abega, SC, Kaona, F., Morison, L, Kaona, F, Hayes, RJ   +18 more
core   +1 more source

Temporal trends and clinical outcomes of antiretroviral therapy initiation and regimens in treatment-naive people with HIV: A real-world study at a tertiary specialist hospital in Beijing, China

Infectious Diseases & Immunity
. Background:. The WHO and international treatment guidelines recommend rapid initiation of antiretroviral therapy (ART) for all treatment-naive (TN) people living with human immunodeficiency virus (HIV) (PLWH).
Jiantao Fu, Ying Liu, Yifan Guo, Jing Chen, Hongxin Zhao, Haijuan Wang   +5 more
doaj   +1 more source

The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.

, 2011
BACKGROUND: The Partners in Prevention HSV/HIV transmission trial (Partners HSV/HIV Transmission Study) showed that herpes simplex virus-2 (HSV-2) suppressive therapy with daily aciclovir could decrease HIV disease progression amongst HIV-1/HSV-2 ...
Mayaud, Philippe, Sinead Delany-Moretlwe, Devine, Angela, Angela Devine, Delany-Moretlwe, Sinead, Peter Vickerman, Vickerman, Peter, Philippe Mayaud, Gesine Meyer-Rath, Foss, Anna M, Anna M. Foss, Meyer-Rath, Gesine   +11 more
core   +1 more source